UniQure to seek approval of Huntington’s gene therapy after FDA U-turn
UniQure has confirmed it will submit its Huntington’s disease gene therapy for regulatory review, after the US Food and Drug…
UniQure has confirmed it will submit its Huntington’s disease gene therapy for regulatory review, after the US Food and Drug…